Parkside Financial Bank & Trust Prothena Corp Public LTD CO Transaction History
Parkside Financial Bank & Trust
- $772 Million
- Q1 2025
A detailed history of Parkside Financial Bank & Trust transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 30 shares of PRTA stock, worth $218. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$218% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
187Shares Held
43.7MCall Options Held
251KPut Options Held
79.2K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$84.4 Million11.27% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$37.9 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$28.1 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.46MShares$25.2 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$16 Million0.41% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $342M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...